CagriSema: Safety Profile Across both pivotal trials, the safety profile of CagriSema was broadly consistent with the established GLP-1 drug class
LiverMultiScan is a Software as a medical Service (SaaS) that is intended to aid the diagnosis and management of chronic liver disease, the most prevalent of which is Non-Alcoholic Fatty Liver Disease (NAFLD)
PEPTIDE THERAPIES Clinician-guided peptide options designed for growth, recovery, fat loss, skin health, and cellular repair, selected based on your goals, labs, and DEXA data
Monitoring During and After Use Prudent monitoring during and after BPC-157 use provides additional reassurance and catches any concerning developments early
Peptides for autoimmune conditions that reduce neuroinflammation and support neural repair could theoretically address both the immune dysregulation and the resulting neural damage